Transabdominal ultrasound is most commonly used to examine the liver, hepatobiliary-pancreatic and urogenital tract. Its use for imaging the intestinal tract is less well established and has been considered more difficult in the past. Improvements in technology and increasing experience with sonographic findings in a variety of intestinal diseases including inflammatory bowel disease (IBD), however, have contributed to firmly establishing the role of ultrasound as a clinically important, non-invasive and widely available imaging modality. In addition, newer techniques such as harmonic imaging and contrast-enhanced ultrasound have recently gained attention. Transabdominal ultrasound is clinically useful in the initial diagnosis of IBD by evaluating bowel wall thickness and surrounding structures including peri-intestinal inflammatory reaction, extent and localization of involved bowel segments and detection of extraluminal complications such as fistula, abscesses, carcinoma and ileus. Transabdominal ultrasound is currently accepted as a clinically important first-line tool in assessing patients with Crohn’s disease irrespective of their clinical symptoms and/or disease activity. It helps to better characterize the course of the disease in individual patients and can guide therapeutic decisions. The topic of this review is to provide an updated overview of the role of transabdominal ultrasound in IBD including Crohn’s disease, ulcerative colitis, tuberculosis and neutropenic colitis while summarizing the results of recent studies with special reference to sensitivity/specificity in detecting the disease and sonomorphologic features to evaluate disease activity and its luminal and extraluminal complications.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.